Skip to content
  • 6,809 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started
Menu

Award notice

Development of CD388 as a long-lasting prophylactic anti-viral option for protection against the health impacts caused by influenza

75A50125C00017

Office of Assistant Secretary for Preparedness and Response, Barda - Aspr / Daappo / Barda DCMA. Research and Development in Biotechnology (except Nanobiotechnology).

18 open like this View on SAM.gov Markdown

Awarded

Cidara Therapeutics Inc.

$339,189,481.00 on the award notice, September 30, 2025, contract 75A50125C00017

Get the next one like this from Office of Assistant Secretary for Preparedness and Response by email, the day it is posted.Find my opportunities

This one was awarded in 2025

18 like it are open now in research and development in biotechnology (except nanobiotechnology)

All 18 open in research and development in biotechnology (except nanobiotechnology)

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Cidara Therapeutics Inc.
UEI
FKP3JZ9RUNY9
CAGE
7A5L2
Vendor location
San Diego, CA
Contract
75A50125C00017, definitive contract
Obligated
$58,051,983.00, potential $339,189,481
Actions
2 between September 30, 2025 and June 2, 2026
Competition
Full and Open Competition, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Development of CD388 as a Long-Lasting Prophylactic Anti-Viral Option for Protection Against the Health Impacts Caused by Influenza
Match
award number 75A50125C00017 equals the contract number; same awarding office 75A501 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. October 14, 2025

    Award notice, originally solicitation

    Awarded to Cidara Therapeutics Inc. for $339,189,481. SAM.gov, notice 0e9dadb61bd9407988920c7bec1d1324

    2 revisions on SAM
    • October 14, 2025: publish, award notice
    • May 29, 2025: publish, solicitation

Points of contact